Researchers tested the combination in vivo and report lower peripheral immune activation and fewer inflammatory gene signatures in the central nervous system.
Recap by typeshit. Post by MDPI Biology on X.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
A quick reaction clip from obesity medicine doctor Spencer Nadolsky responding to a joke about GLP-1 drugs. Light content with no new information.
The obesity medicine director calls prior authorization and step therapy red tape that can stop patients from ever starting a GLP-1, and explains what helps.
Loading…